"Ce centre hospitalier propose depuis de nombreuses années une offre de soins variée et des structures d’accueil adaptées à tous. Quotidiennement, l'équipe médicale pluridisciplinaire répond aux exigences et aux besoins de la population accueillie. Consultez le site pour de plus amples renseignements ou contactez le secrétariat."

During the past decade, Centre Hospitalier Alpes Léman conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Alpes Léman" #1 sponsor was "Intergroupe Francophone de Cancerologie Thoracique" with 13 trials, followed by "ARCAGY/ GINECO GROUP" with 3 trials sponsored, "Hospices Civils de Lyon" with 3 trials sponsored, "UNICANCER" with 3 trials sponsored and "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Alpes Léman" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Alpes Léman" are "Breast Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Small Cell Lung Cancer" (2 trials) and "ALK Gene Rearrangement or ROS1 Gene Rearrangement" (1 trials). Many other conditions were trialed in "Centre Hospitalier Alpes Léman" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Alpes Léman" are "Drug" (25 trials), "Other" (8 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Carboplatin" (2 trials), "Chemotherapy" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Alpes Léman" are 30 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Alpes Léman". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Centre Hospitalier Alpes Léman, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Alpes Léman, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".